Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01036971 · ClinicalTrials.gov registry record
Screening Protocol for the Evaluation of Potential Research Subjects
A clinical trial of Addiction, sponsored by National Institute on Drug Abuse (NIDA).
- Completed
- Registry status
- 6,967
- Enrollment target
- 1
- Study location
NCT01036971 is a study of Addiction that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 6,967 participants, above the 257-participant average among 16 other Addiction trials with a reported enrollment target (2611% higher). The trial reports 1 study location across 1 state.
The verdict
NCT01036971, a study of Addiction, has completed, sponsored by National Institute on Drug Abuse (NIDA).
- COMPLETED
- Registry status
- 6,967 participants
- Enrollment target
- 1
- Study location
Study Summary
Background: \- The Neuroimaging Research Branch of the National Institute on Drug Abuse (NIDA) is interested in developing a pool of potential research participants who may be eligible for research studies on drug abuse and addiction, pharmacological and psychosocial therapies for substance addiction, and the long-term effects of drugs on the development, function, and structure of the brain and other organ systems. To develop this pool of potential participants, researchers intend to screen adolescents and adults who may be eligible for future research studies. Objectives: \- To identify, recruit, and screen participants for NIDA neuroimaging research protocols. Eligibility: \- Individuals 18 years of age and older who are able to provide informed consent. Design: * Eligible participants will undergo two screening interviews: a telephone interview and an in-person interview. The phone interview will determine eligibility for the in-person interview. Adolescents who are eligible for further screening must bring a parent or guardian with them to the in-person interview. * The in-person interview may require up to five visits to the NIDA clinical center. The in-person visit will involve any or all of the following procedures: (1) full physical examination and medical history; (2) psychiatric interview; (3) psychological testing; (4) electrocardiogram; (5) samples of blood, urine, and hair; and (6) other minimally invasive procedures as directed by the research staff. * During the screening process, participants will be explicitly asked for permission to recontact them after the 1-year duration of the screening protocol. For minors, both the adolescent and the parent/guardian must agree to future contact. * No clinical care will be provided under this protocol.
Conditions Studied
Study Locations (1)
Maryland
- National Institute on Drug Abuse, Biomedical Research Center (BRC) - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6,967 participants |
| Start Date | 2006-08-23 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01036971
The ClinicalTrials.gov registry entry for NCT01036971 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 6,967 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 257-participant average among 16 other Addiction trials with a reported enrollment target (2611% higher). The listed sponsor is National Institute on Drug Abuse (NIDA), which has 335 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Addiction appearing as the primary indexed condition, and to 0 interventions.
NCT01036971 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT01036971 about?
NCT01036971 is a clinical study titled "Screening Protocol for the Evaluation of Potential Research Subjects". Background: \- The Neuroimaging Research Branch of the National Institute on Drug Abuse (NIDA) is interested in developing a pool of potential research participants who may be eligible for research studies on drug abuse and addiction, pharmacological and psychosocial therapies for substance addicti...
What is the current status of trial NCT01036971?
This trial is currently completed. The enrollment target is 6,967 participants. The study started on 2006-08-23.
What conditions does trial NCT01036971 study?
This clinical trial studies the following conditions: Addiction.
Who is sponsoring clinical trial NCT01036971?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01036971 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Addiction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Semaglutide Therapy for Alcohol Reduction (STAR)
RECRUITING · Phase 2
-
Tdcs And cogNitive traininG cOmbined for AUD (TANGO)
RECRUITING · NA
-
Computer Game, Qualitative, and MEG/EEG Assessment of Serotonergic Psychedelics
RECRUITING
-
Behavioral and Functional Task Development, Implementation, and Testing
RECRUITING · NA
-
Syringe Service Based Telemedicine and Social Network Driven HIV Prevention Service Implementation
RECRUITING · NA
-
Breathwork-assisted Treatment for Cannabis Use Disorder
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.